Trial of Activated Marrow Infiltrating Lymphocytes Alone or in Conjunction With an Allogeneic Granulocyte Macrophage Colony-stimulating Factor (GM-CSF)-Based Myeloma Cellular Vaccine in the Autologous Transplant Setting in Multiple Myeloma
PHASE2
Patient Population: Patients with active myeloma (Stage II/III) that have c...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILs⢠- NSCLC) Alone or in Combination With Nivolumab With or Without Tadalafil in Locally Advanced and Unresectable or Metastatic NSCLC
PHASE2
The purpose of this study is to determine the safety and efficacy of MILs⢠...